{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:03:02Z","timestamp":1789754582960,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503100"],"award-info":[{"award-number":["82503100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J01101"],"award-info":[{"award-number":["2025J01101"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbcan.2026.189704","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:13Z","timestamp":1789023973000},"page":"189704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tertiary lymphoid structures in pancreatic cancer: molecular mechanisms, heterogeneity, and clinical significance"],"prefix":"10.1016","volume":"1881","author":[{"given":"Youtuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189704_bb0005","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0010","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2026.189704_bb0015","doi-asserted-by":"crossref","first-page":"1324093","DOI":"10.3389\/fimmu.2024.1324093","article-title":"Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.omto.2022.01.010","article-title":"The next wave of cellular immunotherapies in pancreatic cancer","volume":"24","author":"Yeo","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"22","key":"10.1016\/j.bbcan.2026.189704_bb0025","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1056\/NEJMoa2119662","article-title":"Neoantigen T-cell receptor gene therapy in pancreatic cancer","volume":"386","author":"Leidner","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"7963","key":"10.1016\/j.bbcan.2026.189704_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","article-title":"Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer","volume":"618","author":"Rojas","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1470-2045(20)30532-5","article-title":"CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study","volume":"22","author":"O\u2019Hara","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0040","doi-asserted-by":"crossref","first-page":"1286850","DOI":"10.3389\/fimmu.2023.1286850","article-title":"Heterogeneity of tertiary lymphoid structures in cancer","volume":"14","author":"You","year":"2023","journal-title":"Front. Immunol."},{"issue":"6576","key":"10.1016\/j.bbcan.2026.189704_bb0045","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189704_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006698","article-title":"Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance","volume":"11","author":"Zou","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0055","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/2326-6066.CIR-16-0322","article-title":"T-cell localization, activation, and clonal expansion in human pancreatic ductal adenocarcinoma","volume":"5","author":"Stromnes","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0065","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"A","year":"2021","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0070","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0075","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s12672-025-03082-1","article-title":"Impact of tertiary lymphoid structure-associated biomarkers on pancreatic cancer via a dual-disease analysis of psoriasis and pancreatic cancer","volume":"16","author":"Yu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0080","doi-asserted-by":"crossref","first-page":"1222719","DOI":"10.3389\/fimmu.2023.1222719","article-title":"Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2026.189704_bb0085","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s13402-024-00975-1","article-title":"Tertiary lymphoid structures and their therapeutic implications in cancer","volume":"47","author":"Chen","year":"2024","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol."},{"issue":"29","key":"10.1016\/j.bbcan.2026.189704_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108082118","article-title":"Alternative pathways for the development of lymphoid structures in humans","volume":"118","author":"Berteloot","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bbcan.2026.189704_bb0100","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ccell.2026.03.004","article-title":"Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer","volume":"44","author":"Kirschstein","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189704_bb0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fimmu.2012.00350","article-title":"Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: parallels with lymph node stroma","volume":"3","author":"Stranford","year":"2012","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189704_bb0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri3700","article-title":"Ectopic lymphoid-like structures in infection, cancer and autoimmunity","volume":"14","author":"Pitzalis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189704_bb0115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1240859","article-title":"Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma","volume":"5","author":"Poschke","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189312","article-title":"Tertiary lymphoid structures achieve \u2018cold\u2019 to \u2018hot\u2019 transition by remodeling the cold tumor microenvironment","volume":"1880","author":"Cui","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"7791","key":"10.1016\/j.bbcan.2026.189704_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbcan.2026.189704_bb0130","first-page":"273","article-title":"Tertiary lymphoid structures: diversity in their development, composition, and role","volume":"206","author":"Gago Da Gra\u00e7a","year":"2021","journal-title":"J. Immunol. (Baltimore, Md.\u202f: 1950)"},{"issue":"8052","key":"10.1016\/j.bbcan.2026.189704_bb0135","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","article-title":"Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response","volume":"24","author":"Jenkins","year":"2025","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189704_bb0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2019.00847","article-title":"Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4(+) and CD8(+) T-cells","volume":"10","author":"Gorchs","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imr.13189","article-title":"Layered origins of lymphoid tissue inducer cells","volume":"315","author":"van de Pavert","year":"2023","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.20181216","article-title":"Type I interferon induces CXCL13 to support ectopic germinal center formation","volume":"216","author":"Denton","year":"2019","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.169.1.424","article-title":"Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis","volume":"169","author":"Luther","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0170","doi-asserted-by":"crossref","first-page":"13453","DOI":"10.1038\/ncomms13453","article-title":"Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma","volume":"7","author":"Ouyang","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189704_bb0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7150\/thno.105423","article-title":"B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189704_bb0180","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189704_bb0185","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.3389\/fimmu.2019.03070","article-title":"Deciphering the crosstalk between myeloid-derived suppressor cells and regulatory T cells in pancreatic ductal adenocarcinoma","volume":"10","author":"Siret","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0190","doi-asserted-by":"crossref","first-page":"1649812","DOI":"10.3389\/fimmu.2025.1649812","article-title":"The dual immunomodulatory role of B cells in tumorigenesis: mechanisms, microenvironment crosstalk, and therapeutic implications","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189704_bb0195","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/JLB.3MR0218-062R","article-title":"Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer","volume":"104","author":"Nerviani","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"15","key":"10.1016\/j.bbcan.2026.189704_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153678","article-title":"Follicular helper T cells remodel the immune microenvironment of pancreatic cancer via secreting CXCL13 and IL-21","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2020.02.008","article-title":"Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer","volume":"37","author":"Hegde","year":"2020","journal-title":"Cancer Cell"},{"issue":"7592","key":"10.1016\/j.bbcan.2026.189704_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-020-01151-3","article-title":"Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma","volume":"19","author":"Fan","year":"2020","journal-title":"Mol. Cancer"},{"issue":"18","key":"10.1016\/j.bbcan.2026.189704_bb0220","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0225","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s12672-025-02970-w","article-title":"Identification of biomarkers associated with exhausted CD8 +T cells in the tumor microenvironment of intrahepatic cholangiocarcinoma based on Mendelian randomization and bioinformatics analysis","volume":"16","author":"Feng","year":"2025","journal-title":"Discov. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0230","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1158\/2326-6066.CIR-25-0387","article-title":"Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironment","volume":"13","author":"Sidiropoulos","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189704_bb0235","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1085147","article-title":"Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma","volume":"5","author":"Castino","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-producing B cells promote the development of pancreatic neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000189","article-title":"CD200 promotes immunosuppression in the pancreatic tumor microenvironment","volume":"8","author":"Choueiry","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2026.189704_bb0250","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2326-6066.CIR-14-0027","article-title":"Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation","volume":"2","author":"Lutz","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189704_bb0255","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189704_bb0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0167-5699(95)80023-9","article-title":"High endothelial venules (HEVs): specialized endothelium for lymphocyte migration","volume":"16","author":"Girard","year":"1995","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189704_bb0265","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"Ozdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189704_bb0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ebiom.2018.11.030","article-title":"Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: a unique site for targeted delivery","volume":"38","author":"Bahmani","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52553","article-title":"Development and validation of a machine learning model for detection and classification of tertiary lymphoid structures in gastrointestinal cancers","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"7791","key":"10.1016\/j.bbcan.2026.189704_bb0280","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0285","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.21873\/anticanres.18061","article-title":"Immature peritumoral tertiary lymphoid structures indicate poor prognosis in pancreatic ductal adenocarcinoma after NAC","volume":"46","author":"Nabeya","year":"2026","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2026.189704_bb0290","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0295","article-title":"The life cycle of tertiary lymphoid structures in pancreatic cancer-a window of opportunity for immunotherapy","volume":"17","author":"Chen","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0300","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1038\/s41467-023-41880-9","article-title":"Continually recruited na\u00efve T cells contribute to the follicular helper and regulatory T cell pools in germinal centers","volume":"14","author":"Merkenschlager","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0305","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat. Immunol."},{"issue":"385","key":"10.1016\/j.bbcan.2026.189704_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9679","article-title":"Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation","volume":"9","author":"Allen","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"21","key":"10.1016\/j.bbcan.2026.189704_bb0315","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","article-title":"Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment","volume":"184","author":"Lam","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0320","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12957-021-02420-1","article-title":"The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis","volume":"19","author":"Hu","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0325","doi-asserted-by":"crossref","first-page":"1394505","DOI":"10.3389\/fimmu.2024.1394505","article-title":"Tertiary lymphoid structures: new immunotherapy biomarker","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189704_bb0330","doi-asserted-by":"crossref","first-page":"1152551","DOI":"10.3389\/fimmu.2023.1152551","article-title":"Pancreatic cancer: emerging field of regulatory B-cell-targeted immunotherapies","volume":"14","author":"Senturk","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0335","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3748\/wjg.v28.i11.1088","article-title":"B cells in pancreatic cancer stroma","volume":"28","author":"Delvecchio","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0340","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2026.189704_bb0345","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.hpb.2024.04.009","article-title":"Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma","volume":"26","author":"Merali","year":"2024","journal-title":"HPB (Oxford)"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189704_bb0350","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+) tissue-resident memory T-cell response to programmed cell death protein 1 blockade in cancer immunotherapy","volume":"166","author":"Hu","year":"2024","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.bbcan.2026.189704_bb0355","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00535-023-02020-8","article-title":"A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma","volume":"58","author":"Ashina","year":"2023","journal-title":"J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189704_bb0360","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0365","doi-asserted-by":"crossref","DOI":"10.1049\/syb2.70038","article-title":"Integrative analysis of TLS-associated gene signatures, immune infiltration and drug sensitivity in pancreatic Cancer","volume":"19","author":"Gao","year":"2025","journal-title":"IET Syst. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030828","article-title":"Characterization of Estrogen receptors in pancreatic adenocarcinoma with tertiary lymphoid structures","volume":"15","author":"Zou","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189704_bb0375","doi-asserted-by":"crossref","DOI":"10.2174\/0115680266436608260406113212","article-title":"Mendelian randomization analysis of the relationship between neurotransmitter-related genes and cancer: insights from multi-omics data","author":"Yuan","year":"2026","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbcan.2026.189704_bb0380","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jleuko\/qiae067","article-title":"Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immune infiltration in pancreatic cancer","volume":"116","author":"Ma","year":"2024","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0385","doi-asserted-by":"crossref","first-page":"2027148","DOI":"10.1080\/2162402X.2022.2027148","article-title":"Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma","volume":"11","author":"Ahmed","year":"2022","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.bbcan.2026.189704_bb0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00262-025-04205-x","article-title":"Assessment of tertiary lymphoid structures via (18)F-FDG PET\/CT scan in patients with pancreatic adenocarcinoma","volume":"74","author":"Yan","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189704_bb0395","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00262-025-04136-7","article-title":"Comparing neoadjuvant targeted therapy plus transarterial chemoembolization versus triple therapy including immunotherapy in hepatocellular carcinoma: a Chinese multicentre study","volume":"74","author":"Yu","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189704_bb0400","doi-asserted-by":"crossref","first-page":"1378190","DOI":"10.3389\/fimmu.2024.1378190","article-title":"Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma","volume":"15","author":"Rupp","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2026.189704_bb0405","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2026.189704_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116510","article-title":"Targeting tumor-associated sympathetic nerves orchestrates tertiary lymphoid structures to enhance PD-1\/PD-L1 blockade efficacy","volume":"177","author":"Zeng","year":"2026","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189704_bb0415","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12967-025-06152-8","article-title":"Prognostic implications and characterization of tumor-associated tertiary lymphoid structures genes in pancreatic cancer","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"23","key":"10.1016\/j.bbcan.2026.189704_bb0420","doi-asserted-by":"crossref","first-page":"21385","DOI":"10.1021\/acsnano.5c01280","article-title":"Cognate Nanovaccine promotes tertiary lymphoid structures function and strengthens immune cell cross-talk by targeting exhausted T cells in nonimmunogenic cancers","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bbcan.2026.189704_bb0425","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008613","article-title":"Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study","volume":"12","author":"Wang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2026.189704_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006667","article-title":"Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:08:22Z","timestamp":1789751302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0304419X26001769"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189704","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tertiary lymphoid structures in pancreatic cancer: molecular mechanisms, heterogeneity, and clinical significance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189704"}}